S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   426.63 (+0.19%)
AAPL   167.73 (-0.16%)
MSFT   410.34 (-0.36%)
META   506.94 (+2.58%)
GOOGL   156.01 (+0.35%)
AMZN   181.52 (+0.13%)
TSLA   150.09 (-3.45%)
NVDA   855.63 (+1.82%)
AMD   155.85 (+1.19%)
NIO   4.03 (+3.07%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   113.12 (-2.76%)
GE   156.58 (+0.58%)
CGC   7.67 (+18.18%)
DIS   113.43 (+0.43%)
AMC   2.90 (-2.68%)
PFE   25.32 (-0.39%)
PYPL   62.58 (-1.07%)
XOM   118.67 (+0.03%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   426.63 (+0.19%)
AAPL   167.73 (-0.16%)
MSFT   410.34 (-0.36%)
META   506.94 (+2.58%)
GOOGL   156.01 (+0.35%)
AMZN   181.52 (+0.13%)
TSLA   150.09 (-3.45%)
NVDA   855.63 (+1.82%)
AMD   155.85 (+1.19%)
NIO   4.03 (+3.07%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   113.12 (-2.76%)
GE   156.58 (+0.58%)
CGC   7.67 (+18.18%)
DIS   113.43 (+0.43%)
AMC   2.90 (-2.68%)
PFE   25.32 (-0.39%)
PYPL   62.58 (-1.07%)
XOM   118.67 (+0.03%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   426.63 (+0.19%)
AAPL   167.73 (-0.16%)
MSFT   410.34 (-0.36%)
META   506.94 (+2.58%)
GOOGL   156.01 (+0.35%)
AMZN   181.52 (+0.13%)
TSLA   150.09 (-3.45%)
NVDA   855.63 (+1.82%)
AMD   155.85 (+1.19%)
NIO   4.03 (+3.07%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   113.12 (-2.76%)
GE   156.58 (+0.58%)
CGC   7.67 (+18.18%)
DIS   113.43 (+0.43%)
AMC   2.90 (-2.68%)
PFE   25.32 (-0.39%)
PYPL   62.58 (-1.07%)
XOM   118.67 (+0.03%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   426.63 (+0.19%)
AAPL   167.73 (-0.16%)
MSFT   410.34 (-0.36%)
META   506.94 (+2.58%)
GOOGL   156.01 (+0.35%)
AMZN   181.52 (+0.13%)
TSLA   150.09 (-3.45%)
NVDA   855.63 (+1.82%)
AMD   155.85 (+1.19%)
NIO   4.03 (+3.07%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   113.12 (-2.76%)
GE   156.58 (+0.58%)
CGC   7.67 (+18.18%)
DIS   113.43 (+0.43%)
AMC   2.90 (-2.68%)
PFE   25.32 (-0.39%)
PYPL   62.58 (-1.07%)
XOM   118.67 (+0.03%)
Free Trial
OTCMKTS:GNWSD

StageZero Life Sciences (GNWSD) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)
Free GNWSD Stock Alerts
$0.04
+0.01 (+34.48%)
(As of 04/17/2024 ET)
Compare
Today's Range
$0.04
▼
$0.04
50-Day Range
$0.03
▼
$0.04
52-Week Range
$0.17
▼
$0.89
Volume
950 shs
Average Volume
4,987 shs
Market Capitalization
$1.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
GNWSD stock logo

About StageZero Life Sciences Stock (OTCMKTS:GNWSD)

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.

GNWSD Stock Price History

GNWSD Stock News Headlines

April 3, 2024 | msn.com
Building Equity Through Next Generation Science Standards
April 1, 2024 | seekingalpha.com
SZLS:CA StageZero Life Sciences Ltd.
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
March 30, 2024 | msn.com
San Diego biotech news: Veteran life science execs raise $150M for cancer drug targeting hard-to-treat tumors
March 11, 2024 | bizjournals.com
LA, Orange County life-science vacancy rate hits 3%
February 27, 2024 | msn.com
‘An extremely aggressive timeline’: Rhode Island Life Sciences Hub to hire inaugural CEO by May
February 23, 2024 | bizjournals.com
Commentary: Why Boston’s life sciences sector should fuel a new climatetech niche
February 15, 2024 | yahoo.com
Life Below Zero: Next Generation Season 2 Streaming: Watch & Stream Online via Disney Plus
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
November 14, 2023 | finanznachrichten.de
StageZero Life Sciences Ltd: StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
November 14, 2023 | finance.yahoo.com
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
November 10, 2023 | news.yahoo.com
Report: Utah’s life sciences industries are an economic juggernaut on the rise
November 8, 2023 | benzinga.com
Utah Ranks Among Fastest Growing Life Sciences Industries in the Nation
November 7, 2023 | finance.yahoo.com
StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings
October 26, 2023 | theglobeandmail.com
Closing Bell: Stagezero Life Sciences Ltd flat on Thursday (SZLS)
October 23, 2023 | msn.com
Gen Z Is Heading South For More Affordable Homes
October 21, 2023 | theglobeandmail.com
Closing Bell: Stagezero Life Sciences Ltd down on Friday (SZLS)
October 20, 2023 | finanznachrichten.de
StageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings
October 20, 2023 | finance.yahoo.com
StageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer Offerings
October 18, 2023 | theglobeandmail.com
Closing Bell: Stagezero Life Sciences Ltd flat on Wednesday (SZLS)
October 11, 2023 | theglobeandmail.com
Closing Bell: Stagezero Life Sciences Ltd up on Wednesday (SZLS)
October 7, 2023 | theglobeandmail.com
Closing Bell: Stagezero Life Sciences Ltd flat on Friday (SZLS)
September 6, 2023 | msn.com
Geneone Life Science to raise 2.5 bln won via stock offering
June 1, 2023 | bizjournals.com
Here's how much Boston's life sciences industry has grown since 2018
May 31, 2023 | msn.com
Mass. saw a 14.6 percent increase in life sciences jobs during pandemic
May 16, 2023 | finance.yahoo.com
StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update
May 5, 2023 | msn.com
Genemod lands $4.5M for life sciences data storage and collaboration platform
See More Headlines
Receive GNWSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNWSD
CUSIP
N/A
CIK
N/A
Web
www.stagezerolifesciences.com
Phone
(855) 420-7140
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,480,000.00
Net Margins
217.39%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-61.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$140,000.00
Price / Sales
13.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.13) per share
Price / Book
-0.30

Miscellaneous

Outstanding Shares
48,940,000
Free Float
N/A
Market Cap
$1.91 million
Optionable
Not Optionable
Beta
2.97
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • James R. Howard-Tripp
    Executive Chairman & Chief Executive Officer
  • Rebecca Greco
    Head-Investor Relations

Key Competitors

View All Competitors

GNWSD Stock Analysis - Frequently Asked Questions

How have GNWSD shares performed in 2024?

StageZero Life Sciences' stock was trading at $0.0294 at the beginning of the year. Since then, GNWSD shares have increased by 32.7% and is now trading at $0.0390.
View the best growth stocks for 2024 here.

How do I buy shares of StageZero Life Sciences?

Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GNWSD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Urgent alert: open this for a huge profit potential
Timothy Sykes
Fed launches fourth dollar overhaul
Stansberry Research
New Trump Bombshell
The Freeport Society